Disclosed herein are compounds pharmaceutical compositions and related methods for the treatment of viral infection including RNA viral infection in subjects. The compounds pharmaceutical compositions and methods can modulate the innate immune antiviral response in vertebrate cells including activating the RIG I pathway.